WeVote
Log In

Bill

Bill

A 2397

Requires DOH to develop a payment methodology for federally qualified health centers and rural health centers that dispense ovulation enhancing drugs

2025 Regular Session Introduced by Amy Paulin and 1 co-sponsor

DOH must craft a payment method to reimburse FQHCs and RHCs for dispensing ovulation-enhancing drugs, improving access and simplifying billing.

REFERRED TO HEALTH
0
WeVote Research Nonpartisan
Bill Summary · A 2397

Summary of Bill A 2397

Overview

Bill A 2397 would require the New York Department of Health (DOH) to develop a payment methodology for federally qualified health centers (FQHCs) and rural health centers (RHCs) that dispense ovulation-enhancing drugs. Introduced on January 16, 2025 and currently referred to the Health Committee, the bill seeks to establish how these centers are reimbursed for dispensing such medications.

Purpose and intent

  • To ensure a formal, structured approach to reimbursement for ovulation-enhancing drugs dispensed by FQHCs and RHCs.
  • Aims to clarify payment terms to support access to infertility-related medications provided through community-based health centers.

Key provisions

  • DOH must develop a payment methodology for reimbursements to FQHCs and Rural Health Centers that dispense ovulation-enhancing drugs.
  • The bill does not specify the exact elements of the methodology within the provided text (e.g., payment rates, billing codes, or patient cost-sharing). The DOH would determine the detailed components as part of implementing the methodology.

Who would be affected

  • Primary recipients: Federally Qualified Health Centers and Rural Health Centers that dispense ovulation-enhancing drugs.
  • Other impacts may be indirect, including patients who obtain these medications at FQHCs/RHCs and pay under the new methodology, as well as the DOH, which would oversee development and implementation.

Procedural and timeline aspects

  • Introduced: January 16, 2025.
  • Status: REFERRED TO HEALTH (Health Committee). The bill has not yet advanced to passage; no explicit deadlines or implementation dates are provided in the available information.
  • Legislative actions show two identical referral entries on January 16, 2025.

Sponsors and related bills

  • Primary sponsor: Amy Paulin.
  • Cosponsor: Nily Rozic.
  • Related / companion bills: A 9840 (prior-session) and S 1794 (companion) indicate cross-chamber interest in the same policy concept.

Notes

  • Details of the payment methodology (rates, structure, applicability, and implementation timeline) are not specified in the summary provided. Stakeholders may want to review the full bill text for exact provisions once available and monitor subsequent committee actions for updates.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.